• Hover over video and click the volume icon for sound

Welcome to the Colorado State University

Research Innovation Center


  • Meeting rooms
  • Break rooms
  • Reception
  • Mail service
  • CSU electronic library system access
  • Access to vivarium, laboratory animal services, and major equipment cores for mass spectrometry and next generation sequencing


  • Total Area: 17,000 sq. ft.
  • Total Office Area: 1,700 sq. ft.
  • Total Lab Area: 7,500 sq. ft.
  • 21 Labs: 140 – 700 sq. ft.
  • Located at the CSU Foothill campus
  • Office space located next to flexible, BSL-2 wet lab space
  • High security facility, monitored 24x7


  • Access to university major equipment core facilities
  • Eligibility to hire CSU student interns, paid for by CSU
  • Life science business advisory services available
  • Ideal location for establishing collaborative R&D relationships with world-class CSU faculty
diagonal line

Current Tenant Companies


E-Flux strives to solve environmental problems with unique and simple solutions. Products include Fossil Fuel Traps, which were conceived as a cost-effective solution to the complex problem of accurately measuring petroleum biodegredation rates in soil at petroleum spill sites. The second product offering, Map Traps, utilize similar but less sensitive testing capabilities. Map Traps are used to delineate petroleum based contaminated areas by providing a binary (yes / no) indication of the presence of petroleum. A third product, BioTherm, is a web-based thermal modeling tool used to enhance the conceptual site model.


PhotonPharma is developing its InnocellTM antigen presenting technology for personalized same-day immunotherapy for solid or liquid tumors.

SiVEC Biotechnologies:

SiVEC Biotechnologies is committed to developing antiviral products for the rapid prevention of economically important diseases. SiVEC’s patent pending antiviral technology, SiVEC-AIV™, can be rapidly applied as a large-scale aerosol to prevent avian flu in poultry, thereby significantly reducing the economic impact of this disease worldwide.


VeriPrime Research Division has been actively engaged in researching oxidative stress in feedlot cattle for over four years, and just recently in dairy cattle. Oxidative stress encompasses the effect of environment, nutrition, stage of production, muscle accretion, milk production, and management practices on the overall production of metabolic toxins and their impact on redox equilibrium within cellular systems. Disruption of the normal redox equilibrium leads to cellular damage, apoptosis, DNA damage, and detrimental changes in cellular messenger systems, all of which contribute to disease, distress, and inefficient production of meat and milk.

Vivaldi Biosciences:

Vivaldi Biosciences is a clinical-stage biotechnology company developing live attenuated influenza vaccines (LAIVs) to address the most pressing public health issues of influenza: the need for a rapid and effective response to emerging pandemics with vaccines that are easily administered, safe and protective, and the need for vaccines that protect the most vulnerable populations – seniors and young children – against seasonal influenza. These age groups suffer disproportionately from influenza and its serious complications, but are poorly served by conventional influenza vaccines.


Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2018, the company generated annual revenue of $5.8 billion with approximately 10,000 employees. For more information, visit https://www.zoetisus.com/

Interested in Applying for a Space?

Fill out an application and email to idrc-coordinator@colostate.edu